346 related articles for article (PubMed ID: 11236120)
1. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy.
Sowter MC; Farquhar CM; Petrie KJ; Gudex G
BJOG; 2001 Feb; 108(2):192-203. PubMed ID: 11236120
[TBL] [Abstract][Full Text] [Related]
2. Conservative management of tubal ectopic pregnancy.
van Mello NM; Mol F; Mol BW; Hajenius PJ
Best Pract Res Clin Obstet Gynaecol; 2009 Aug; 23(4):509-18. PubMed ID: 19299204
[TBL] [Abstract][Full Text] [Related]
3. Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study.
Guvendag Guven ES; Dilbaz S; Dilbaz B; Aykan Yildirim B; Akdag D; Haberal A
Acta Obstet Gynecol Scand; 2010 Jul; 89(7):889-95. PubMed ID: 20583934
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy.
Sowter MC; Farquhar CM; Gudex G
BJOG; 2001 Feb; 108(2):204-12. PubMed ID: 11236121
[TBL] [Abstract][Full Text] [Related]
5. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial.
Krag Moeller LB; Moeller C; Thomsen SG; Andersen LF; Lundvall L; Lidegaard Ø; Kjer JJ; Ingemanssen JL; Zobbe V; Floridon C; Petersen J; Ottesen B
Acta Obstet Gynecol Scand; 2009; 88(12):1331-7. PubMed ID: 19961341
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy.
Hajenius PJ; Engelsbel S; Mol BW; Van der Veen F; Ankum WM; Bossuyt PM; Hemrika DJ; Lammes FB
Lancet; 1997 Sep; 350(9080):774-9. PubMed ID: 9297998
[TBL] [Abstract][Full Text] [Related]
7. [Medical treatment of unruptured ectopic pregnancy].
Rojas Mora E; Hernández Vivar LE; Sánchez Contreras J; Risco Cortés RJ; Pulido Olivares VH
Ginecol Obstet Mex; 2004 Apr; 72():135-41. PubMed ID: 15318753
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
[TBL] [Abstract][Full Text] [Related]
9. Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy.
Kazandi M; Turan V
Clin Exp Obstet Gynecol; 2011; 38(1):67-70. PubMed ID: 21485731
[TBL] [Abstract][Full Text] [Related]
10. Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy.
Debby A; Golan A; Sadan O; Zakut H; Glezerman M
BJOG; 2000 May; 107(5):626-30. PubMed ID: 10826577
[TBL] [Abstract][Full Text] [Related]
11. Assessment of β-human chorionic gonadotropin level as a reliable predictor of tubal patency confirmed with transvaginal ultrasound-guided selective salpingography (TVSSG) following conservative treatment of tubal pregnancy.
Al Sayed I
Arch Gynecol Obstet; 2012 Apr; 285(4):1043-8. PubMed ID: 22002409
[TBL] [Abstract][Full Text] [Related]
12. Tubal patency after local methotrexate injection for tubal pregnancy.
Pansky M; Bukovsky I; Golan A; Weinraub Z; Schneider D; Langer R; Arieli S; Caspi E
Lancet; 1989 Oct; 2(8669):967-8. PubMed ID: 2571874
[TBL] [Abstract][Full Text] [Related]
13. Resolution of hormonal markers of ectopic gestation: a randomized trial comparing single-dose intramuscular methotrexate with salpingostomy.
Saraj AJ; Wilcox JG; Najmabadi S; Stein SM; Johnson MB; Paulson RJ
Obstet Gynecol; 1998 Dec; 92(6):989-94. PubMed ID: 9840564
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate injection of tubal ectopic pregnancy. A logical evolution?
Thompson GR; O'Shea RT; Seman E
Med J Aust; 1991 Apr; 154(7):469-71. PubMed ID: 1826038
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the indication for and limitation of laparoscopic salpingotomy for tubal pregnancy.
Fujishita A; Khan KN; Kitajima M; Hiraki K; Miura S; Ishimaru T; Masuzaki H
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):210-6. PubMed ID: 17459564
[TBL] [Abstract][Full Text] [Related]
16. Treatment of tubal pregnancy in the netherlands: an economic comparison of systemic methotrexate administration and laparoscopic salpingostomy.
Mol BW; Hajenius PJ; Engelsbel S; Ankum WM; Hemrika DJ; Van der Veen F; Bossuyt PM
Am J Obstet Gynecol; 1999 Oct; 181(4):945-51. PubMed ID: 10521759
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
[TBL] [Abstract][Full Text] [Related]
18. Intratubal methotrexate for prevention of persistent ectopic pregnancy after salpingotomy.
Kaya H; Babar Y; Ozmen S; Ozkaya O; Karci M; Aydin AR; Ozbasar D
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):464-7. PubMed ID: 12386357
[TBL] [Abstract][Full Text] [Related]
19. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.
Mol F; Mol BW; Ankum WM; van der Veen F; Hajenius PJ
Hum Reprod Update; 2008; 14(4):309-19. PubMed ID: 18522946
[TBL] [Abstract][Full Text] [Related]
20. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial.
van Mello NM; Mol F; Adriaanse AH; Boss EA; Dijkman AB; Doornbos JP; Emanuel MH; Friederich J; Leeuw-Harmsen Lv; Lips JP; van Santbrink EJ; Verhoeve HR; Visser H; Ankum WM; Veen Fv; Mol BW; Hajenius PJ
BMC Womens Health; 2008 Jun; 8():10. PubMed ID: 18565217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
